{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4494"}, "official-title": {"#tail": "\n\t", "#text": "To launch a national strategy to support regenerative medicine through funding for research and\n\t\t\t commercial development of regenerative medicine products and development\n\t\t\t of a regulatory environment that enables rapid approval of safe and\n\t\t\t effective products, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140428", "#text": "April 28, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for herself and ", "#text": "Ms. DeGette", "@name-id": "D000197"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Paulsen", "@name-id": "P000594"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H285C87E1CA204B8683B6B61A229FDB42", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title; table of contents"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"short-title": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Regenerative Medicine Promotion Act of 2014", "@value": "Regenerative Medicine Promotion Act of 2014", "@proposed": "true"}, "#text": "\n              "}, "#tail": ".", "#text": "\n            "}, "#text": "This Act may be cited as the "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Short title"}, "#text": "\n        ", "@id": "H12DD6D8B062D4931B08E982F151F69E3"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "The table of contents of this Act is as follows:"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Table of contents"}, "toc": {"@container-level": "legis-body-container", "#tail": "\n\t\t\t", "@lowest-level": "section", "@regeneration": "yes-regeneration", "toc-entry": [{"@idref": "H16C96D624D844B8893CCDE481CA51275", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20021.\u2002Short title; table of contents.", "@level": "section"}, {"@idref": "HF655A93109FB4B3BADCAD6C369DA8E28", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20022.\u2002Findings.", "@level": "section"}, {"@idref": "H4CA54209D99A4FC69A00AAF960A80027", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20023.\u2002Report on ongoing Federal programs and activities regarding regenerative medicine.", "@level": "section"}, {"@idref": "H929EFFD38A094CD0AD2C9A7FB68CC33D", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20024.\u2002Establishment of Regenerative Medicine Coordinating Council.", "@level": "section"}, {"@idref": "H1E896A123DE44DCFA432F5BEFEBAFEB0", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20025.\u2002Grants for basic or preclinical research into regenerative medicine.", "@level": "section"}, {"@idref": "HF8889E1FCC364DF2AC7C5688D87FF3BF", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20026.\u2002Grants for development of drugs, biological products, medical devices, and biomaterials for\n\t\t\t use in regenerative medicine.", "@level": "section"}, {"@idref": "HBD6A79CC31584D5BB62A3DB046B1AD4D", "#tail": "\n\t\t\t\t\t", "#text": "Sec.\u20027.\u2002Supporting innovation in regenerative medicine through cures acceleration network.", "@level": "section"}, {"@idref": "H04247BCD794341439A28BE6726202C7A", "#tail": "\n\t\t\t\t", "#text": "Sec.\u20028.\u2002Funding for Food and Drug Administration research.", "@level": "section"}], "@quoted-block": "no-quoted-block", "@lowest-bolded-level": "division-lowest-bolded", "#text": "\n\t\t\t\t\t"}, "#text": "\n        ", "@id": "HCCAE9B16F7C6454EBE4BDC212D7AECD3"}], "#text": "\n      ", "@id": "H16C96D624D844B8893CCDE481CA51275"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds the following:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Regenerative medicine has the potential to treat many chronic diseases, promote economic growth,\n\t\t\t and reduce health care spending in the United States."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H0222EF1E4F26422398CBE71F42020F59", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Regenerative medicine products have already successfully treated numerous health conditions, and\n\t\t\t have the potential to provide cures, treatments, and diagnostics for a\n\t\t\t range of diseases and disabilities including diabetes, spinal cord injury,\n\t\t\t heart disease, stroke, and various forms of cancer."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H2557DB8BAA5D45A8A876289BC0205380", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "A United States national strategy on regenerative medicine is critical to ensure that this\n\t\t\t technology fulfills its potential to cure and treat diseases and\n\t\t\t disabilities, reduce overall health spending, and promote economic growth."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "H0239B821845B4C1DB4A32DFCEF697586", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has stated that regenerative medicine has the potential to treat many\n\t\t\t battlefield injuries such as burns, that it has the potential to heal\n\t\t\t wounds without scarring, and that it has the potential to be used for\n\t\t\t traumatic brain injury and other forms of trauma, craniofacial\n\t\t\t reconstruction, limb reconstruction, regeneration, and transplantation.", "@entity-type": "federal-body", "#text": "Department of Defense", "@entity-id": "9700"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H8355D76FD3184F388FAFEFA28FC1F017", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and the Multi-Agency Tissue Engineering Science\n\t\t\t Interagency Working Group have endorsed a national initiative to support\n\t\t\t research and product development in regenerative medicine.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "H8FC5F000BAF74A94A1D7B355AB9EDD36", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has said the potential benefits of regenerative\n\t\t\t medicine in improved health care and economic savings are enormous. States\n\t\t\t that have invested in regenerative medicine have experienced economic\n\t\t\t growth and see future growth potential, including an increase in biotech\n\t\t\t employment, payroll increases, and proportional impacts on tax receipts.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "H943001EDBE5E44AC8149AC59F2AE892E", "#text": "\n        "}], "#text": "\n      ", "@id": "HF655A93109FB4B3BADCAD6C369DA8E28"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall provide for the completion, and submission to the\n\t\t\t Congress, of a report identifying all ongoing Federal programs and\n\t\t\t activities regarding regenerative medicine.", "@entity-type": "federal-body", "#text": "Comptroller General of the\n\t\t\t United States", "@entity-id": "0500"}, "#text": "Not later than 180 days after the date of the enactment of this Act, the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Report on ongoing Federal programs and activities regarding regenerative medicine"}, "#text": "\n      ", "@id": "H4CA54209D99A4FC69A00AAF960A80027"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Establishment of Regenerative Medicine Coordinating Council"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, within six months of the enactment of\n\t\t\t this Act, in the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ", a ", "@entity-type": "federal-body", "#text": "Office of the Secretary", "@entity-id": "750S"}, {"@proposed": "true", "#tail": " (in this section referred to as the ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Regenerative Medicine\n\t\t\t Coordinating Council"}], "#text": "The ", "quote": {"#tail": ").", "#text": "Council"}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Establishment"}, "#text": "\n        ", "@id": "HE8FA86365887412292146A7E1A71B3C2"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall be composed of the following:", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Composition"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Commerce", "@entity-id": "1300"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H3AF7D23591F344EB97D3684ABC161B48", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Defense", "@entity-id": "9700"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H4630F7D3F9AE414AA8206C1F9DF90361", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H2055EEE218B241FC8DEC7779AB24422A", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of the Treasury", "@entity-id": "2000"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H0528A7B8A50B42E9935B2CEEF29AB5FA", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary of Veterans Affairs", "@entity-id": "3600"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "H1512137F87454D6C83E3DFC0AF3156A3", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Administrator of the Agency for Healthcare Research and Quality", "@entity-id": "7528"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "HDF4457CDFC914EA89A9A83BF9CAB778E", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Administrator of the Centers for Medicare & Medicaid Services", "@entity-id": "7530"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "H23E137E7774540EA95EB489183BB9586", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(8)"}, "@id": "HF5974A0FAF224F8EA331530E92947C0F", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Health", "@entity-id": "7529"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(9)"}, "@id": "HB628D48ED9F841DDB959B450BC692DE1", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Standards and Technology", "@entity-id": "1341"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(10)"}, "@id": "H172B0E257353420D8A57AE57E2B7EFDC", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)", "@value": "Regenerative Medicine Promotion Act of 2014/s:4/ss:d", "@proposed": "true"}], "#text": "The members appointed by the "}, "enum": {"#tail": "\n          ", "#text": "(11)"}, "@id": "H1E95E43A6D4B47A4BF88B3056D0A18FC", "#text": "\n          "}], "#text": "\n        ", "@id": "HB7F3D6583A6D499E9076D5991B256D69"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be the Chair of the Council.", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Chair"}, "#text": "\n        ", "@id": "HCFD63125B44E424BB04BD355A8CA7654"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall appoint at least 5 persons to serve as members of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " under ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, {"#tail": ". The members of the Council appointed under the preceding sentence\n\t\t\t shall include persons with expertise in third-party payment, regenerative\n\t\t\t medicine researchers from academic institutions, patient advocates,\n\t\t\t persons with expertise in drug discovery, persons with expertise in drug\n\t\t\t development, persons with expertise in basic research, persons with\n\t\t\t expertise in translational research, persons with expertise in medical\n\t\t\t device development, persons with expertise in biomaterials, clinicians,\n\t\t\t and persons with expertise in clinical research.", "@entity-type": "act", "#text": "subsection\n\t\t\t (b)(11)", "@value": "Regenerative Medicine Promotion Act of 2014/s:4/ss:b/p:11", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Members appointed by secretary"}, "#text": "\n        ", "@id": "H0A8D01C4F5814B39BC0D70ADA86569E4"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall\u2014", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Functions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for purposes\n\t\t\t of implementing any recommendations in the report required by ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "act", "#text": "section 3", "@value": "Regenerative Medicine Promotion Act of 2014/s:3", "@proposed": "true"}], "#text": "consult with, and provide information to, the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HA63C42F51B2E4EB1BF3D03C1D22A33AA", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "prepare, and keep up-to-date, a national strategy to support research into regenerative medicine\n\t\t\t and the development of drugs, biological products, medical devices, and\n\t\t\t biomaterials for use in regenerative medicine;"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H155A9A73DF8A4FC98406EECB995705C5", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "prepare a plan specifying priorities for research into regenerative medicine;"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H9473F7BB3B6D4B0C88ADAA8FD55F2F85", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "sections 5", "@value": "Regenerative Medicine Promotion Act of 2014/s:5", "@proposed": "true"}, {"#tail": " (relating to grants for basic or\n\t\t\t preclinical research into regenerative medicine and for development of\n\t\t\t drugs, biological products, medical devices, and biomaterials for use in\n\t\t\t regenerative medicine, respectively);", "@entity-type": "act", "#text": "6", "@value": "Regenerative Medicine Promotion Act of 2014/s:6", "@proposed": "true"}], "#text": "not later than 1 year after the date of the enactment of this Act, establish priorities for the\n\t\t\t award of grants under "}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H1B3A0D5AC7074A05998804AD1A932E50", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "identify sources of funding for research into regenerative medicine;"}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "HF1C97579A3AD41DB9518525BACDD0B99", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "identify areas where such funding is inadequate;"}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "HC6A852A84CEA413AA19C5388862B2856", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "make recommendations regarding Federal regulatory, reimbursement, tax, and other policies that will\n\t\t\t support development and marketing of regenerative medicine products;"}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "H72B3BC57FF4041A582B38B2D7A837744", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "facilitate development of consensus standards regarding scientific issues critical to regulatory\n\t\t\t approval of regenerative medicine products; and"}, "enum": {"#tail": "\n          ", "#text": "(8)"}, "@id": "H6F9A2C0105614A889B4C8B7420E9415C", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "determine the need for establishing centers of excellence or consortia to further advance\n\t\t\t regenerative medicine."}, "enum": {"#tail": "\n          ", "#text": "(9)"}, "@id": "H0F679ACDBDB14594BD59186B68105178", "#text": "\n          "}], "#text": "\n        ", "@id": "H6000268E8A1B43A48D95508A724E8DFB"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Transparency; reporting requirements"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " shall adopt procedures to ensure the receipt of public input, such as holding public\n\t\t\t stakeholder meetings or creating advisory boards.", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Transparency"}, "#text": "\n          ", "@id": "H53F1E434C2D047B4A57E690BBBAFF190"}, {"#tail": "\n      ", "@id": "H917E6FB260C440FF9FA292F27C3F2618", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Annual reports"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall submit an annual report on its activities to the ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", and the ", "@entity-type": "federal-body", "#text": "Director of the\n\t\t\t National Institutes of Health", "@entity-id": "7529"}, {"#tail": ".\n\t\t\t Each such report shall\u2014", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}], "#text": "The "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": " for regenerative medicine;", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "provide details on progress in meeting goals identified by the "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H7F981033CB82490AB2B2822972FFD9AF", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ";", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Council"}, "#text": "make recommendations regarding funding, regulatory, or other policies to achieve regenerative\n\t\t\t medicine goals identified by the "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HB90ED02B4B714F98AC6D7DD6E85804FE", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "identify all regenerative medicine products currently on the market and those in development;"}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "@id": "HCCD6EDEA1104439C8A41FAD7A8E6B7AE", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "identify regenerative medicine research and technological advances and discoveries that occurred in\n\t\t\t the previous year; and"}, "enum": {"#tail": "\n            ", "#text": "(D)"}, "@id": "H2B61E23B432D44E0AFB27E00FE0D1B1C", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "assess the impact of regenerative medicine on the Nation\u2019s economy, including with respect to\u2014"}, "enum": {"#tail": "\n            ", "#text": "(E)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the number of people employed in companies or research institutions working in regenerative\n\t\t\t medicine;"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H506AD8FEE8CB4799AFE82DE550080B57", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the number of companies pursuing regenerative medicine products;"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H243BBD29D8AD4F41A84A208062019AD4", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "increases in tax revenues; and"}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "H13BC943E8EA246B68E4CFE485C019A06", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "the impact on national health spending."}, "enum": {"#tail": "\n              ", "#text": "(iv)"}, "@id": "HAEB646DDCDFA4111B7DB2AFAD1C5EC9B", "#text": "\n              "}], "#text": "\n            ", "@id": "H9EE4300BCF6D487F99DEEF3AB1C577FF"}]}], "#text": "\n        ", "@id": "H43106B158016484895AAF71CB27A9FF6"}], "#text": "\n      ", "@id": "H929EFFD38A094CD0AD2C9A7FB68CC33D"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n\t\t\t", "#text": "Grants for basic or preclinical research into regenerative medicine"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may make grants to eligible entities for the purpose of funding basic or preclinical\n\t\t\t research into regenerative medicine.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Grants for basic or preclinical research"}, "#text": "\n        ", "@id": "H1DAA5AF041D249D99FD49CF520EF90F9"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may make a grant under this section for research only if\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Conditions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the research is carried out directly by the grant recipient;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H0BF3EA089D694E60B4EAF50C3D88B2F1", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the research is partly funded by one or more private entities; and"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HB0B48BDD516A42ADAB80EAB96A37F970", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "the amount of the grant does not exceed the total amount provided for the research by private\n\t\t\t entities (other than the grant recipient itself)."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "HF48C52CA08E54F65B488616F2DE8C55C", "#text": "\n          "}], "#text": "\n        ", "@id": "H03BF9B4E837A49E78C37F4413FB45E22"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines\n\t\t\t appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A grant under this section may be made on such terms and conditions as the "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Terms and conditions"}, "#text": "\n        ", "@id": "HB16626E738B84710A1C072E09342FD44"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall take into consideration the priorities\n\t\t\t established by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " under\n\t\t\t ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Regenerative Medicine Coordinating Council"}, {"#tail": ".", "@entity-type": "act", "#text": "section 4(e)", "@value": "Regenerative Medicine Promotion Act of 2014/s:4/ss:e", "@proposed": "true"}], "#text": "In awarding grants under this section, the "}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Priority"}, "#text": "\n        ", "@id": "H67568DCEEFDE4BAC87B36ED98B2A99CF"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "In this section:"}, "enum": {"#tail": "\n        ", "#text": "(e)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means a nonprofit entity or an institution of higher education.", "#text": "eligible entity"}, "#text": "The term "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H72F96C1C92704A9CBACDA05A3F90C6A8", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " has the meaning given that term in ", "#text": "institution of higher education"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 101 of the Higher Education Act of 1965", "@value": "Higher Education Act of 1965/s:101"}, {"#tail": ")", "@entity-type": "uscode", "#text": "20 U.S.C.\n\t\t\t 1001", "@value": "usc/20/1001"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H3FE0763D8CEE4EB6A94AFBA705EB3D08", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": " means an entity that\u2014", "#text": "nonprofit entity"}, "#text": "The term "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "H952EA0866E4C4DF0AB30FB7B5B4479E5", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "is described in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "\n                  ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/501", "#text": "section 501(c)(3)", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:501/ss:c/p:3"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "26 U.S.C. 501(c)(3)", "@value": "usc/26/501/c/3"}, "@parsable-cite": "usc/26/501", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H49B8DA122A5845998B6D6E9CB746334A", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "is exempt from tax under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "\n                  ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/501", "#text": "section 501(a)", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:501/ss:a"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "26 U.S.C. 501(a)", "@value": "usc/26/501/a"}, "@parsable-cite": "usc/26/501", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HA63A3E3533254B9A95DE0D83A3EE4CFE", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means the ", "#text": "Secretary"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the National\n\t\t\t Institutes of Health", "@entity-id": "7529"}]}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H0B00331ECF7947E7B21F26C0175F6704", "#text": "\n          "}], "#text": "\n        ", "@id": "H507D4CB7463E4149B793F25219D05D47"}], "#text": "\n      ", "@id": "H1E896A123DE44DCFA432F5BEFEBAFEB0"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n\t\t\t", "#text": "Grants for development of drugs, biological products, medical devices, and biomaterials for use in\n\t\t\t regenerative medicine"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may make grants to eligible entities for the purpose of funding projects that have as\n\t\t\t their aim\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Grants for drug development"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the research and development of drugs, biological products, medical devices, and biomaterials for\n\t\t\t use in regenerative medicine; and"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HEBE3203B24A543E1B976D6A2462A40B1", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "the making of an investigational new drug application with respect to such drugs or biological\n\t\t\t products, or the making of an investigational device exemption application\n\t\t\t with respect to such devices, by not later than the end of the 4-year\n\t\t\t period beginning on the date on which such grant is made."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HBA600425FF7B4D8FB66A207B2C185C2D", "#text": "\n          "}], "#text": "\n        ", "@id": "HDF0581B3495246C4BB2F73CDF4D6477C"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines\n\t\t\t appropriate.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A grant under this section may be made on such terms and conditions as the "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Terms and conditions"}, "#text": "\n        ", "@id": "H5FD2AFE97C294380B434FBBCA0892CC9"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall take into consideration the priorities\n\t\t\t established by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " under\n\t\t\t ", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Regenerative Medicine Coordinating Council"}, {"#tail": ".", "@entity-type": "act", "#text": "section 4(e)", "@value": "Regenerative Medicine Promotion Act of 2014/s:4/ss:e", "@proposed": "true"}], "#text": "In awarding grants under this section, the "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Priority"}, "#text": "\n        ", "@id": "HFC8CA5163F9143F6B18C4053B676D6FF"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "In this section:"}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " has the meaning given the term in ", "#text": "biological product"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 351(i) of the Public Health Service Act", "@value": "Public Health Service Act/s:351/ss:i"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 262(i)", "@value": "usc/42/262/i"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H46D2D8D1BA84417A93D598804BBBDFED", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and ", "#text": "drug"}, {"#tail": " have the meanings given to the terms ", "#text": "medical device"}, {"#tail": " and ", "#text": "drug"}, {"#tail": ", respectively, in ", "#text": "device"}], "#text": "The terms ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 201 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:201"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 321", "@value": "usc/21/321"}, "@parsable-cite": "usc/21/321", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HDCFE43F4D59247DFB030856D3ACED64F", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": " means a collaborative partnership including\u2014", "#text": "eligible entity"}, "#text": "The term "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "H4017EF0E8E7F4F35BD1D04CA563AB90A", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "a qualified nonprofit entity or an institution of higher education; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HE9D1E95222CA497FAFA26422935B082D", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "a for-profit entity."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "HD90901E71A8A45CBBC0FEED8D8293B38", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " has the meaning given that term in ", "#text": "institution of higher education"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 101 of the Higher Education Act of 1965", "@value": "Higher Education Act of 1965/s:101"}, {"#tail": ")", "@entity-type": "uscode", "#text": "20 U.S.C.\n\t\t\t 1001", "@value": "usc/20/1001"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H3A346BD0CD0947ADAEBF9E84EA7B3F2E", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means an investigational new drug application that is made to the ", "#text": "investigational new drug application"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 505(i) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:i"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 505(i)", "@value": "usc/21/505/i"}], "@entity-type": "law-citation", "#text": "\n              "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t under ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "H09683E72932948D2B8C769A09686CEC4", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means an application for an investigational device exemption that is made to the ", "#text": "investigational device exemption application"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 520(g) of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:520/ss:g"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 360j(g)", "@value": "usc/21/360j/g"}, "@parsable-cite": "usc/21/360j", "#text": "\n              ", "@legal-doc": "usc"}}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " under ", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "H286FC8F903F64BD5971BC9164B83C792", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "quote": {"#tail": " means an entity that\u2014", "#text": "qualified nonprofit entity"}, "#text": "The term "}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "#text": "\n          ", "@id": "H6633405CB2B94A5687025706F37DA4CA", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "is described in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "\n                  ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/501", "#text": "section 501(c)(3)", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:501/ss:c/p:3"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "26 U.S.C. 501(c)(3)", "@value": "usc/26/501/c/3"}, "@parsable-cite": "usc/26/501", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HE43D1BC1EC934C4A8918CF156AE325F5", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "is exempt from tax under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "\n                  ", "external-xref": {"#tail": " of the Internal Revenue Code of 1986", "@parsable-cite": "usc/26/501", "#text": "section 501(a)", "@legal-doc": "usc"}, "@value": "Internal Revenue Code of 1986/s:501/ss:a"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "26 U.S.C. 501(a)", "@value": "usc/26/501/a"}, "@parsable-cite": "usc/26/501", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H013D530B2E3848ABA97CA49D1F25525C", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means the ", "#text": "Secretary"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Director of the National\n\t\t\t Institutes of Health", "@entity-id": "7529"}]}, "enum": {"#tail": "\n          ", "#text": "(8)"}, "@id": "H8A859A2A33804BF496E762A703FE6A74", "#text": "\n          "}], "#text": "\n        ", "@id": "HFCD464C8F5DA41808193077DC5CE64BD"}], "#text": "\n      ", "@id": "HF8889E1FCC364DF2AC7C5688D87FF3BF"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 480 of the Public Health Service Act", "@value": "Public Health Service Act/s:480"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "42 U.S.C. 287a", "@value": "usc/42/287a"}, "@parsable-cite": "usc/42/287a", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "Supporting innovation in regenerative medicine through cures acceleration network"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by adding at the end the following:", "@entity-type": "act", "#text": "subsection (d)", "@value": "Public Health Service Act/s:480/ss:d"}, "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "; and"}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ".", "@entity-type": "federal-body", "@value": "Regenerative Medicine Coordinating Council", "@entity-parent-id": "750S", "#text": "Regenerative Medicine Coordinating Council"}, "#text": "With respect to activities of the Board relating to medical products and behavioral therapies for\n\t\t\t use in regenerative medicine, the Board shall collaborate with the\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(7)"}, "header": {"#tail": "\n            ", "#text": "Collaboration"}, "#text": "\n            ", "@id": "HF44B0F02A4F64C5588EEDC99808B7865"}, "#text": "\n\t\t\t\t\t", "@id": "H4554D6BCECEB4784BF9174BF04473BC5"}, "#text": "\n        ", "@id": "HF2D3CC72D8884183AA5B12A357ABCFBC"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by adding at the end the following:", "@entity-type": "act", "#text": "subsection (e)(3)", "@value": "Public Health Service Act/s:480/ss:e/p:3"}, "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subparagraph": {"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " or\n\t\t\t studies which use good manufacturing practice or good laboratory practice\n\t\t\t procedures and the data from which are intended for inclusion in an\n\t\t\t investigational new drug application or an investigational device\n\t\t\t exemption application; or", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, "#text": "to perform clinical trials under a protocol approved by the "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H0CA0EE0E8E7D4773906AC1D125FCFBB4", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "to perform basic research or preclinical studies in regenerative medicine the data from which are\n\t\t\t not intended for inclusion in an investigational new drug application or\n\t\t\t an investigational device exemption application."}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H42D6499B262D4499B9456881B56B3E5B", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(D)"}, "header": {"#tail": "\n            ", "#text": "The cures acceleration awards with respect to products and therapies for use in regenerative\n\t\t\t medicine"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, without regard to ", "@entity-type": "federal-body", "#text": "Director of NIH", "@entity-id": "7529"}, {"#tail": ", ", "@entity-type": "act", "#text": "subparagraphs (A)", "@value": "Public Health Service Act/s:480/ss:e/p:3/sp:A"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(B)", "@value": "Public Health Service Act/s:480/ss:e/p:3/sp:B"}, {"#tail": ", provide assistance\n\t\t\t under ", "@entity-type": "act", "#text": "(C)", "@value": "Public Health Service Act/s:480/ss:e/p:3/sp:C"}, {"#tail": " with respect to medical products and behavioral\n\t\t\t therapies for use in regenerative medicine, including assistance\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:480/ss:e/p:1"}], "#text": "The "}, "#text": "\n            ", "@id": "H0C63599AD6D745F2BA5A21E4AA697CB4"}, "#text": "\n\t\t\t\t\t", "@id": "HBCA68A34F9D543FDB93AC8946DE0886D"}, "#text": "\n        ", "@id": "HCB7A293367A5479EBD64F112DCAA9D18"}], "#text": "\n      ", "@id": "HBD6A79CC31584D5BB62A3DB046B1AD4D"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "8."}, "header": {"#tail": "\n\t\t\t", "#text": "Funding for Food and Drug Administration research"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Grants"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to perform its functions with respect to regenerative\n\t\t\t medicine; or", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t Drug Administration", "@entity-id": "7524"}, "#text": "conduct, support, or collaborate in regulatory research for the purpose of assisting the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H64B8C97D85BB417B90498A609A1DC7A0", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "make grants to fund regulatory research for such purpose."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H4004B036D3FC463FA07A48F236816051", "#text": "\n          "}], "#text": "\n        ", "@id": "HE89D89CAF174447AA3B7CE6F4980C165"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "In this section:"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means research regarding development, evaluation, and availability of new or improved tools,\n\t\t\t methods, standards, and applied science that support a better\n\t\t\t understanding and improved evaluation of product safety, quality,\n\t\t\t effectiveness, and manufacturing throughout the product life cycle.", "#text": "regulatory research"}, "#text": "The term "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H43A0CA5A93BD4D7688A2557CE926C785", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " means the ", "#text": "Secretary"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Commissioner of Food and\n\t\t\t Drugs", "@entity-id": "7524"}]}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HE9EBDE1E44DB4023A61E0EEB03BB0745", "#text": "\n          "}], "#text": "\n        ", "@id": "HDF3FDE00AB564CCE88013A9FDE8C3C62"}], "#text": "\n      ", "@id": "H04247BCD794341439A28BE6726202C7A"}], "#text": "\n\t\t", "@id": "H2C4EEFC258C04F66A9B7D5F0B6CA07D9"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-04-28"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4494 IH: Regenerative Medicine Promotion Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}